Investorideas.com

Get great ideas from our AI, cannabis, cleantech, crypto, esports and mining podcasts - be a guest or sponsor : 800 665 0411


Share on StockTwits

Investor Ideas Potcasts, Cannabis News and Stocks on the Move; Episode 428 (NASDAQ: NEPT) (TSX: NEPT) (TSX:TGOD) (NASDAQ: GNLN) (OTC: PSYC)

Delta, Kelowna, BC - June 15, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2020/061520-StocksToWatch.mp3

Investor Ideas Potcasts, Cannabis News and Stocks on the Move; Episode 428 (NASDAQ: NEPT) (TSX: NEPT) (TSX:TGOD) (NASDAQ: GNLN) (OTC: PSYC)

SHARE PODCAST:      

Hear Investor ideas cannabis potcast on iTunes

Hear the investor ideas potcast on Spotify

Today's podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today's podcast we look at a few public company announcements.

Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT), a diversified and fully integrated health and wellness company, announce today that the Company's Health & Wellness Innovations division has launched Neptune Halo, an electronic pulse oximeter device that is a key tool in the battle against COVID-19.

According to the American Lung Association, the pulse oximeter observes a rapid measurement of oxygen saturation level in the body without using needles or taking a blood sample, which alerts users to seek medical help if their oxygen levels are too low.

In an April 24th, New York Times article, Dr. Richard Levitan, an emergency physician in Littleton, N.H, commented: "Patients with COVID-19 can experience a potentially dangerous drop in oxygen saturation without having obvious breathing problems. Without a pulse oximeter, they might never know it or get very used to how they feel, despite very low oxygen levels. By the time they go to the hospital feeling shortness of breath, their oxygen levels would have dropped significantly, and they could have very advanced COVID pneumonia."

Neptune Health & Wellness Innovations is rapidly bringing new products to market to address market demand for critical health and wellness products such as Neptune Halo oximeter, the Neptune Air non-contact thermometer, as well as hand sanitizer products and other innovations in development. The Company is preparing a B2B and B2C strategy to bring Neptune Halo and Neptune Air to market via partnerships with national retailers and direct-to-consumers through its own e-commerce platform and e-commerce partners.

"Neptune Halo is another example of Neptune's ability to rapidly respond to market needs and deliver high quality products at value pricing as a diversified and fully integrated health and wellness company," said Michael Cammarata, Chief Executive Officer of Neptune Wellness Solutions. "We are proud to do our part to help people better monitor their health and identify when a COVID infection is reducing oxygen levels."

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTC:TGODF), a leading producer of premium certified organic cannabis, announced that it has expanded its exclusive licensing agreement with Colorado-based Stillwater Brands, it will be rolling out the powerful RIPPLE suite of products in Canada, including RIPPLE Gummies and RIPPLE QuickSticks.

Leveraging Stillwater's proprietary technology, TGOD launched its first Cannabis 2.0 product at the end of March - TGOD Infuser 10mg THC - which quickly became one of the top selling SKUs within the beverage category across the country. Given the success of this first product, TGOD has decided to expand the series by introducing additional formats. Moving forward, all formats will fall under the well-established RIPPLE brand name.

RIPPLE products have made a name for themselves in the United States, garnering multiple awards since their launch in 2016, including:

  • The Dope Cup (Best Drink) - 2017
  • Leafly (Best Overall Product) - 2018
  • LeafLink (Best Selling Edible) - 2019

All three RIPPLE dissolvables are currently in the Top 10 most-sold cannabis beverages in Colorado, including the number one spot for RIPPLE Pure 10.

"Soluble cannabinoids are the future of functional foods," commented Justin Singer, CEO of Stillwater Brands. "Similar to what we saw in Colorado, the Canadian market was overrun by inconsistent, low-quality products early on. Novelty can only carry a product so far. Ultimately, consistency and predictability are what keep consumers coming back. The success of RIPPLE in Colorado proves the value of our commitment to quality above all, and TGOD's commitment to organic, high-quality products makes them an ideal partner to carry our vision beyond the U.S."

On their own, ingested cannabinoids such as THC are poorly absorbed by the body. It can take hours to feel the effects of edibles that rely on butter- or tincture-based formulations, a situation that too often leads to disappointment. In contrast, RIPPLE relies on proprietary solubilization technology to render THC and CBD water-soluble, allowing these cannabinoids to enter the bloodstream and are proven to begin generating effects within 15 minutes of ingestion. RIPPLE's unique chemistry and best-in-class production controls lead to products that are fast-acting, consistent, and reliable - in other words, exactly what consumers have been waiting for.

"We are thrilled to leverage the strength of RIPPLE's intellectual property here in Canada. Not only are we adding their chewables and QuickSticks to our portfolio, we are also harnessing the power of their proprietary technology in other products such as our teas," said Brian Athaide, CEO of TGOD. "RIPPLE provides novel and proven effective dose-controlled delivery methods that are faster-acting, more standardized, and more discreet than most products currently on the market. Consumers have quickly adopted them, and that's the best recognition we can get as a new CPG company," added Athaide.

Greenlane Holdings, Inc. (NASDAQ: GNLN), one of the largest global sellers of premium cannabis accessories, child-resistant packaging, and specialty vaporization products, today unveiled G-Verify, a consumer-facing, scannable verification program that allows brands to communicate product information directly to consumers. Powered by Lucid Green's Lucid ID platform, G-Verify can be used by brands to confirm product authenticity, share manufacturing certifications, child-resistant compliance details, reviews, dosage, and educational content through unique QR codes.

G-Verify harnesses the power of Lucid Green's 36,000 registered users and up to 600 daily scans per brand to provide reliable product, safety, and educational information directly to consumers and retailers. Each G-Verify Lucid ID is conveniently printed on product packaging and can be easily scanned with any smartphone camera. Greenlane's latest offering in partnership with Lucid Green assures consumers that every aspect of their favorite products, from the packaging to the hardware or cannabis itself, is verified and compliant, and provides critical information regarding lab testing and safety.

BRANDS

Greenlane brands that opt into G-Verify will have direct-to-consumer control over their own brand narrative. Each G-Verify brand landing page provides real-time updates regarding product information, compliance testing results, marketing assets, and brand messaging. G-Verify Lucid ID codes seamlessly integrate into existing compliance labeling machinery and easily prints directly within existing compliance labels. In addition, brands will receive monthly consumer data reports that can be leveraged to update marketing content and drive sales. Most importantly, G-Verify proactively verifies that a product is authentic, protecting brands from intellectual property theft.

DISPENSARIES

G-Verify acts as a virtual brand ambassador that can be easily utilized by budtenders to provide product expertise at point-of-sale. In addition to enhancing in-store customer experiences, G-Verify provides comprehensive employee training and guidelines regarding best practices and ongoing product education. G-Verify brands seamlessly integrate with existing retailer POS systems, which allows retailers to verify product authenticity, certifications, and compliance, and even review product testing results in real-time. Upon registration, retailers will gain access to brand marketing assets which can be used to drive sales and customer engagement.

CONSUMERS

Any consumer with a smartphone can access critical product information including dosage recommendations, reviews, ingredient breakdowns, batch information, and certifications. Consumers can even track their personal experience with products without downloading additional applications. G-Verify's landing page also allows consumers to explore verified customer reviews, industry articles, and related blogs about participating products or brands. Unlike other compliance solutions, the G-Verify platform also acts as a digital wallet that tracks purchases and rewards points, allowing consumers to redeem exclusive gifts and offers.

"The legal cannabis retail environment is still challenging space for consumers, brands, and dispensaries to navigate," said Aaron LoCascio, Co-Founder and CEO of Greenlane. "The illicit market is actively competing with legal companies for customers, which is a serious threat to consumer safety. G-Verify's partnership with Lucid Green delivers a vital platform that allows cannabis enthusiasts to buy and sell consumption products with peace of mind."

Global Trac Solutions, Inc. (OTC: PSYC) announced that Psychedelic Spotlight has distributed to its subscribers the first edition of its Micro-Dose Monthly newsletter as part of the Company's next step in developing its platform as a leading communications channel for the emerging industry of medicinal psychedelics. The newsletter is the culmination of the company's insights to introduce the important work being done within the psychedelic space.

Not only are psychedelics showing promise as FDA-designated "breakthrough therapies," but they may also be key to expanding consciousness through scientific discoveries on how these substances interact with the brain, and now, the accelerated progress of these studies have just created unprecedented investment opportunities with the industry's leading companies going public this year. Psychedelics is providing hope for millions with the potential to treat mental health disorders.

The Micro-Dose Monthly newsletter, written by Kent Sligh of PSYC, will provide thoughts on three sections of the industry, which are medicinal progress, lifestyle/entertainment, and investing opportunities.

"Psychedelic medicine and the opportunities to invest in these emerging therapies are all new to me, and it's exciting to get a chance to learn and write about such complex and vital subjects," said Kent Sligh. "After thousands of years as medicinal and spiritual tools used in various cultures, to its mid-20th century discovery by western scientists, followed by criminalized classification and decades-long scientific abandonment, psychedelics as medicine are finally experiencing transformative and historic progress while creating a dynamic new industry in the process. I believe, PSYC recognizes this as its binding message in developing its original content and platform as a reliable and intriguing source that attracts readers and contributors, alike."

"At a time when our world needs hope and healing like never before, I believe that the newsletter strikes the right tone and balance between application and entertainment to introduce our subscribers to the re-emergence of psychedelics as a global therapeutic," said Jason LeBlanc, Global Business Consultant. "We look forward to seeing where this journey takes us."

The Company encourages those who are interested in receiving the newsletter, and those who wish to stay current with the latest insights on trends and growth associated with medicinal psychedelics, to subscribe at the Psychedelic Spotlight homepage.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

Hear Investor ideas cannabis potcast on iTunes

Hear the investor ideas potcast on Spotify

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining the AI Eye.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

Follow us on Cannabis Social Media

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/investorideas_potcast/

Download our Mobile App for iPhone and Android

Contact Investorideas.com

800-665-0411


Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories

Buy a cannabis guest post on Investorideas.com